Evidence map›Paper›PMID 36839634›Full record

ReviewPharmaceutics2023

Regulation of

Kannappan Arunachalam, Poonguzhali Pandurangan, Chunlei Shi, Ricardo Lagoa

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2026
    Review
  3. Review
  4. Article
  5. Cell surface (Amsterdam, Netherlands) · 2025
    Review
  6. Prevalence ofIndian journal of microbiology · 2025
    Article
  7. Antibiotics (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Avicenna journal of medical biotechnology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Kannappan ArunachalamMOST-USDA Joint Research Center for Food Safety, Department of Food Science and Technology, School of Agriculture and Biology, and State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University, Minhang, Shanghai 200240, China.ORCID 0000-0001-5958-8900
Poonguzhali PanduranganDepartment of Microbiology, M.R. Government Arts College, Mannargudi, Coimbatore 614001, Tamil Nadu, India.ORCID 0000-0001-5752-2959
Chunlei ShiMOST-USDA Joint Research Center for Food Safety, Department of Food Science and Technology, School of Agriculture and Biology, and State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University, Minhang, Shanghai 200240, China.ORCID 0000-0002-5847-7122
Ricardo LagoaSchool of Technology and Management, Polytechnic Institute of Leiria, 2411-901 Leiria, Portugal.ORCID 0000-0003-2375-6612
Shanghai Jiao Tong University · CNUniversity of Lisbon · PT

Funding

Fundação para a Ciência e Tecnologia UIDP/04378/2020 UIDB/04378/2020National Natural Science Foundation of China 31972169National Natural Science Foundation of China 32001798Science and Technology Commission of Shanghai Municipality 21N31900200
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibacterial activitybiofilm inhibitiondrug deliverynanotechnologyStaphylococcus aureus

Identifiers

PMID36839634
PMCPMC9960757
OpenAlexW4317036207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.